Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Monte Rosa Therapeutics (GLUE) Tax Rate (2023 - 2025)

Historic Tax Rate for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to 10.5%.

  • Monte Rosa Therapeutics' Tax Rate rose 108000.0% to 10.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.73%, marking a year-over-year increase of 50700.0%. This contributed to the annual value of 3.71% for FY2024, which is 34600.0% down from last year.
  • As of Q3 2025, Monte Rosa Therapeutics' Tax Rate stood at 10.5%, which was up 108000.0% from 10.81% recorded in Q2 2025.
  • In the past 5 years, Monte Rosa Therapeutics' Tax Rate ranged from a high of 14.06% in Q4 2024 and a low of 10.81% during Q2 2025
  • For the 3-year period, Monte Rosa Therapeutics' Tax Rate averaged around 1.31%, with its median value being 0.31% (2024).
  • Its Tax Rate has fluctuated over the past 5 years, first skyrocketed by 140000bps in 2024, then tumbled by -99700bps in 2025.
  • Quarter analysis of 3 years shows Monte Rosa Therapeutics' Tax Rate stood at 0.07% in 2023, then surged by 21170bps to 14.06% in 2024, then decreased by -25bps to 10.5% in 2025.
  • Its last three reported values are 10.5% in Q3 2025, 10.81% for Q2 2025, and 1.72% during Q1 2025.